(a)
CRR3
they are used for the purpose of mitigating CVA risk and are managed as such;
← b) · All articles · b) →
Source: EUR-Lex (Cellar) · retrieved 2026-09-25 · Text as adopted (Official Journal); later amendments are not incorporated in this text.